Researchers are studying how they impact a range of different health issues including (but not limited to): Sleep apnea Metabolic disorders Neurodegenerative disorders Substance use disorders Liver disease Arthritis Inflammatory bowel disease Completing research studies and gaining FDA approval for new use cases takes time, but it looks likely that GLP-1s could be prescribed as treatment for a growing list of health issues in the coming years
Kaiser's internal appeals process has a timeline, and waiting too long can limit your options
Moreover, integration of continuous glucose monitoring (CGM) enables doses of GLP-1 to be titrated in real-time in response to GI patterns and closed-loop systems are under development, which may automatically regulate the delivery of medication
Excited to see what happens after a few more months
A simple target for many people is: 0.7 to 1.0 grams of protein per pound of goal body weight per day
To, K., Cao, R., Yegiazaryan, A., Owens, J., Nguyen, T., Sasaninia, K., Vaughn, C., Singh, M., Truong, E., Medina, A., Avitia, E., Villegas, J., Pham, C., Sathananthan, A
